Literature for GEMSA (XM14.001 inhibitor)

(Topics flags: S Structure, I Inhibitor. To select only the references relevant to a single topic, click the link above. See explanation.)

2008
1. Marx,P.F., Brondijk,T.H., Plug,T., Romijn,R.A., Hemrika,W., Meijers,J.C. and Huizinga,E.G.
   Crystal structures of TAFI elucidate the inactivation mechanism of activated TAFI: a novel mechanism for enzyme autoregulation
   Blood112, 2803-2809. PubMed  Europe PubMed DOI  S  I
2003
2. [YEAR:14-3-2003]Walker,J.B., Hughes,B., James,I., Haddock,P., Kluft,C. and Bajzar,L.
   Stabilization versus inhibition of TAFIa by competitive inhibitors in vitro
   J Biol Chem278, 8913-8921. PubMed  Europe PubMed DOI  I
2002
3. [YEAR:28-6-2002]Chen,Y.Y., Cross,K.J., Paolini,R.A., Fielding,J.E., Slakeski,N. and Reynolds,E.C.
   CPG70 Is a novel basic metallocarboxypeptidase with C-terminal polycystic kidney disease domains from Porphyromonas gingivalis
   J Biol Chem277, 23433-23440. PubMed  Europe PubMed DOI  I
2001
4. [YEAR:11-5-2001]Aloy,P., Companys,V., Vendrell,J., Aviles,F.X., Fricker,L.D., Coll,M. and Gomis-Ruth,F.X.
   The crystal structure of the inhibitor-complexed carboxypeptidase D domain II and the modeling of regulatory carboxypeptidases
   J Biol Chem276, 16177-16184. PubMed  Europe PubMed DOI  S  I
1999
5. [YEAR:24-3-1999]Novikova,E.G. and Fricker,L.D.
   Purification and characterization of human metallocarboxypeptidase Z
   Biochem Biophys Res Commun256, 564-568. PubMed  Europe PubMed DOI  I
6. [YEAR:23-4-1999]Qian,Y., Varlamov,O. and Fricker,L.D.
   Glu300 of rat carboxypeptidase E is essential for enzymatic activity but not substrate binding or routing to the regulated secretory pathway
   J Biol Chem274, 11582-11586. PubMed  Europe PubMed DOI  I
1998
7. [YEAR:23-1-1998]Boffa,M.B., Wang,W., Bajzar,L. and Nesheim,M.E.
   Plasma and recombinant thrombin-activable fibrinolysis inhibitor (TAFI) and activated TAFI compared with respect to glycosylation, thrombin/thrombomodulin-dependent activation, thermal stability, and enzymatic properties
   J Biol Chem273, 2127-2135. PubMed  Europe PubMed DOI  I
8. [YEAR:9-1-1998]Day,R., Lazure,C., Basak,A., Boudreault,A., Limperis,P., Dong,W. and Lindberg,I.
   Prodynorphin processing by proprotein convertase 2. Cleavage at single basic residues and enhanced processing in the presence of carboxypeptidase activity
   J Biol Chem273, 829-836. PubMed  Europe PubMed DOI  I
1995
9. Song,L. and Fricker,L.D.
   Purification and characterization of carboxypeptidase D, a novel carboxypeptidase E-like enzyme, from bovine pituitary
   J Biol Chem270, 25007-25013. PubMed  Europe PubMed DOI  I
1984
10. [YEAR:10-10-1984]Strittmatter,S.M., Lynch,D.R. and Snyder,S.H.
    [3H]Guanidinoethylmercaptosuccinic acid binding to tissue homogenates. Selective labeling of enkephalin convertase
    J Biol Chem259, 11812-11817. PubMed  Europe PubMed  I
1983
11. [YEAR:29-3-1983]Fricker,L.D., Plummer,T.H., Jr. and Snyder,S.H.
    Enkephalin convertase: potent, selective, and irreversible inhibitors
    Biochem Biophys Res Commun111, 994-1000. PubMed  Europe PubMed  I
1978
12. [YEAR:7-2-1978]McKay,T.J. and Plummer,T.H., Jr.
    By-product analogues for bovine carboxypeptidase B
    Biochemistry17, 401-405. PubMed  Europe PubMed  I